Arkolith/Insider Trading/QNCX/Form 4

Hannah Brendan

CBO, COO & CCOQuince Therapeutics, Inc. (QNCX) · full profile →Form 4 · filed Dec 8, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 5, 2025Option exercise(M)25K$0.94$24K362K
Dec 5, 2025Option exercise(M)2K$0.55$1K337K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 5, 2025Option exercise(M)25K—$0200K
Dec 5, 2025Option exercise(M)2K—$045K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000912282-25-001370) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML